Alaunos Therapeutics reported $970K in Current Assets for its fiscal quarter ending in March of 2026.





Current Assets Change Date
Alaunos Therapeutics USD 970K 1.02M Mar/2026
Amgen USD 34.96B 3.49B Jun/2026
AstraZeneca USD 27.97B 1.65B Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Biogen USD 7.31B 1.88B Jun/2026
Bioline Rx USD 21.58M 2.1M Mar/2026
Bristol-Myers Squibb USD 28.58B 1.37B Jun/2026
Celltrion KRW 481.57B 10.97B Mar/2026
Corcept Therapeutics USD 439.68M 13.64M Jun/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Curis USD 16.61M 9.7M Mar/2026
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 897.54M 222.37M Jun/2026
Divis Laboratories Ltd INR 110.96B 12.53B Mar/2026
Gilead Sciences USD 12.53B 6.11B Jun/2026
GlaxoSmithKline GBP 17.56B 202M Jun/2026
Incyte USD 6.03B 542.31M Jun/2026
Intrexon USD 23.72M 45.04M Jun/2024
Ionis Pharmaceuticals USD 2.49B 446.73M Jun/2026
J&J USD 59.77B 601M Jun/2026
Kangmei Pharma CNY 6.8B 225.83M Mar/2026
Karyopharm Therapeutics USD 126.33M 23.19M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Merck USD 35.02B 8.5B Mar/2026
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Novartis USD 27.35B 744M Jun/2026
Organigram Holdings CAD 250.09M 6.46M Mar/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pfizer USD 41.36B 1.46B Jun/2026
Pharma Mar EUR 280.95M 7.5M Jun/2026
PTC Therapeutics USD 2.62B 363.36M Jun/2026
Qiagen NV USD 1.54B 454.82M Mar/2026
Regeneron Pharmaceuticals USD 18.45B 236.8M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sartorius EUR 1.64B 280M Jun/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
TG Therapeutics USD 1.09B 456.2M Mar/2026
Tilray USD 729.32M 28.18M Sep/2025
Verastem USD 202.9M 20.51M Mar/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 11.43B 728.95M Mar/2026